M007...what do you call the strategy where you buy at

Shaky Ground Beneath AppLovin's Feet Ah, the sweet smell of litigation in the tech space—it’s like déjà vu for seasoned market folks. Here we have AppLovin, nestled comfortably in San Francisco, now eying a saucy class-action lawsuit. We're looking at shareholders taking a firm stance against some arguably misleading claims. We're talking big deals with allegations...

Changing the Game with Lifestyle Medicine When it comes to healthcare, you're always going to have the skeptics grousing about the old ways. But what happens when you take an old idea and turbocharge it with modern tech? That's where the American College of Lifestyle Medicine (ACLM) and eClinicalWorks step in. They’re throwing a new wrench into the electronic health...

Transitioning Power in the CPA World Let's cut to the chase—when a seasoned CPA like Joseph Rabinowitz picks up the phone to secure a succession partner, it's a big deal. Enter ZBS Group LLP, steered by Michael Zaidman, which isn't a stranger to these waters, undertaking their fourth CPA practice acquisition through Rabinowitz's corner of the accounting universe....

Spotlight on Emerging Titans: The Future 100 Watchlist The Sovereign Wealth Fund Institute is rattling the investment cages with their latest stunt, the 'Future 100 Watchlist.' Hot off the press, this list is parading nearly 3,000 start-ups that are biting at the heels of future success. It's high stakes and higher hopes between December 11-16 at Miami's I20 Summit, where...

A Monumental Launch with Deep Roots I've been around long enough to see all sorts of moves in the art world and the tech world. But what Artprice by Artmarket is pulling off here—it’s a doozy. Thierry Ehrmann’s “Diálogo entre un pensador y la IA” just went live in Spanish, and that’s not some paperback thrill ride. We’re talking about an 1,800-page piece of...

Tulsa's New Spotlight: Gradient's CHROMA Event Well, look at Tulsa, becoming the center of the tech and enterprise universe for a day. Gradient is throwing open the doors for its second annual CHROMA event on September 24, 2026. You might scratch your head and say, ‘Tulsa? Really?’ But hear me out—this isn’t just a local shindig. We're talking about a one-day...

Unpacking SOPHiA GENETICS' Third Quarter Figures Let's cut through the jargon and get straight to the brass tacks. SOPHiA GENETICS (NASDAQ:SOPH) just posted their third quarter numbers for 2026, and it’s a mixed bag, my friends. Sure, they boasted a 25% bump in revenue, hitting $24.3 million, but the devil's in the details—net losses nudged up to $20.3 million, not...

Marathon's Profit Skyrockets Marathon Petroleum Corp. (NYSE: MPC) just pulled off a Houdini act in the third quarter of 2026, as they reported a staggering net income of $7.4 billion. Compare that to last year's third quarter profits of $1.4 billion, and it's like comparing a sumo wrestler with a featherweight fighter. This transformation isn't just a fluke, it's a result...

Breaking New Ground at the NYSE When the bell rings at the NYSE these days, it's not just marking the start of another trading session. It's the sound of change clanging its way onto Wall Street. On November 3, 2026, the NYSE threw its hat deeper into the tokenization ring, a game-changer perhaps. They've roped in some big guns—Securitize, tZERO, Broadridge Financial...

Singapore's Bold Step into Precision Medicine When it comes to revolutionizing healthcare, Singapore isn't content to sit on the sidelines. They've just thrown a serious hat into the ring with the SG-INSIGHT study, a cornerstone of their National Precision Medicine programme. And Illumina, Inc. (NASDAQ:ILMN) is right there in it, gearing up to sequence the genomes of...

Understanding the Expanding Krill Meal Market The krill meal market is undergoing remarkable growth, fueled by a shift in consumer preferences favoring clean-label food products and natural flavor enhancers. According to recent estimates, the market is poised to expand significantly, reaching an impressive valuation by the end of an upcoming decade. This growth can be...

Tango Therapeutics Begins Dosing in Pivotal Cancer Trial BOSTON — Tango Therapeutics, Inc. (NASDAQ: TNGX), a dynamic biotechnology company dedicated to revolutionizing cancer care, has achieved a pivotal milestone by dosing the first patient in its TNG456 Phase 1/2 trial aimed at patients with MTAP-deleted solid tumors, particularly glioblastoma (GBM). Known for its...

Investors Encouraged to Join Class Action Against Rentokil Initial Bronstein, Gewirtz & Grossman, LLC, a well-respected law firm known for its expertise in securities cases, is reaching out to investors of Rentokil Initial Plc. This communication centers around a class action lawsuit that has been filed on behalf of those affected by some significant events concerning the...

Murphy USA's Dividend Boost Reflects Confidence in Growth Murphy USA Inc. (NYSE: MUSA), a well-known player in the gasoline and convenience store sector, has recently announced an increase in its quarterly cash dividend. The company's Board has declared a new dividend of $0.48 per share, which represents a notable 6.7% rise from the previous dividend. This increase...

Cloudinary's Innovative Update to Digital Asset Management Today, Cloudinary, the leading image and video platform, revealed significant advancements in its API-first digital asset management (DAM) solution. These enhancements are designed to address the evolving needs of brands in managing their visual assets efficiently and effectively. With a focus on streamlining...